<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">51093</article-id><article-id pub-id-type="doi">10.7554/eLife.51093</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Modulation of dopamine D<sub>1</sub> receptors via histamine H<sub>3</sub> receptors is a novel therapeutic target for Huntington's disease</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-158403"><name><surname>Moreno-Delgado</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-158401"><name><surname>Puigdellivol</surname><given-names>Mar</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-158364"><name><surname>Moreno</surname><given-names>Estefanía</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189035"><name><surname>Rodríguez-Ruiz</surname><given-names>Mar</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-158405"><name><surname>Botta</surname><given-names>Joaquín</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6450-1267</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-158404"><name><surname>Gasperini</surname><given-names>Paola</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-158361"><name><surname>Chiarlone</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-158406"><name><surname>Howell</surname><given-names>Lesley A</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-158402"><name><surname>Scarselli</surname><given-names>Marco</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-158362"><name><surname>Casadó</surname><given-names>Vicent</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-158363"><name><surname>Cortés</surname><given-names>Antoni</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-157878"><name><surname>Ferré</surname><given-names>Sergi</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-41692"><name><surname>Guzmán</surname><given-names>Manuel</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-158365"><name><surname>Lluís</surname><given-names>Carmen</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182385"><name><surname>Alberch</surname><given-names>Jordi</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8684-2721</contrib-id><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-157889"><name><surname>Canela</surname><given-names>Enric I</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4992-7440</contrib-id><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-86248"><name><surname>Ginés</surname><given-names>Silvia</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-122325"><name><surname>McCormick</surname><given-names>Peter J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2225-5181</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Biochemistry</institution>, <institution>University of Barcelona</institution>, <addr-line><named-content content-type="city">Barcelona</named-content></addr-line>, <country>Spain</country></aff><aff id="aff2"><institution content-type="dept">Biomedical Science</institution>, <institution>University of Barcelona</institution>, <addr-line><named-content content-type="city">Barcelona</named-content></addr-line>, <country>Spain</country></aff><aff id="aff3"><institution content-type="dept">Centre for Endocrinology</institution>, <institution>William Harvey Research Institute, Queen Mary University of London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff4"><institution content-type="dept">CIBIO</institution>, <institution>University of Trento</institution>, <addr-line><named-content content-type="city">Trento</named-content></addr-line>, <country>Italy</country></aff><aff id="aff5"><institution content-type="dept">Deparment of Biochemistry and Molecular Biology</institution>, <institution>Instituto Ramon y Cajal de Investigacion Sanitaria, Universidad Complutense</institution>, <addr-line><named-content content-type="city">Madrid</named-content></addr-line>, <country>Spain</country></aff><aff id="aff6"><institution content-type="dept">Chemistry</institution>, <institution>Queen Mary University of London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff7"><institution content-type="dept">Pharmacology</institution>, <institution>University of Pisa</institution>, <addr-line><named-content content-type="city">Pisa</named-content></addr-line>, <country>Italy</country></aff><aff id="aff8"><institution content-type="dept">NIDA</institution>, <institution>National Institutes of Health</institution>, <addr-line><named-content content-type="city">Baltimore</named-content></addr-line>, <country>United States</country></aff><aff id="aff9"><institution content-type="dept">Biomedical Sciences, Institute of Neuroscience</institution>, <institution>University of Barcelona</institution>, <addr-line><named-content content-type="city">Barcelona</named-content></addr-line>, <country>Spain</country></aff><aff id="aff10"><institution content-type="dept">Biochemistry and Molecular Bomedicine</institution>, <institution>University of Barcelona</institution>, <addr-line><named-content content-type="city">Barcelona</named-content></addr-line>, <country>Spain</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1079"><name><surname>Dötsch</surname><given-names>Volker</given-names></name><role>Reviewing editor</role><aff><institution>Goethe University</institution>, <country>Germany</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>silviagines@ub.edu</email> (SG);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>p.mccormick@qmul.ac.uk</email> (PM);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>09</day><month>06</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e51093</elocation-id><history><date date-type="received"><day>14</day><month>08</month><year>2019</year></date><date date-type="accepted"><day>26</day><month>05</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Moreno-Delgado et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Moreno-Delgado et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-51093-v1.pdf"/><abstract><p>Early Huntington's disease (HD) include over-activation of dopamine D<sub>1</sub> receptors (D<sub>1</sub>R), producing an imbalance in dopaminergic neurotransmission and cell death. To reduce D<sub>1</sub>R over-activation, we present a strategy based on targeting complexes of D<sub>1</sub>R and histamine H<sub>3</sub> receptors (H<sub>3</sub>R). Using an HD mouse striatal cell model and HD mouse organotypic brain slices we found that D<sub>1</sub>R-induced cell death signaling and neuronal degeneration, are mitigated by an H<sub>3</sub>R antagonist. We demonstrate that the D<sub>1</sub>R-H<sub>3</sub>R heteromer is expressed in HD mice at early but not late stages of HD, correlating with HD progression. In accordance, we found this target expressed in human control subjects and low-grade HD patients. Finally, treatment of HD mice with an H<sub>3</sub>R antagonist prevented cognitive and motor learning deficits and the loss of heteromer expression. Taken together, our results indicate that D<sub>1</sub>R - H<sub>3</sub>R heteromers play a pivotal role in dopamine signaling and represent novel targets for treating HD.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>BBSRC CASE</institution></institution-wrap></funding-source><award-id>MCCORMICK_U15BB</award-id><principal-award-recipient><name><surname>McCormick</surname><given-names>Peter J</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>RSC Grant Project</institution></institution-wrap></funding-source><award-id>RG140118</award-id><principal-award-recipient><name><surname>McCormick</surname><given-names>Peter J</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>BBSRC</institution></institution-wrap></funding-source><award-id>BB/N504282/3</award-id><principal-award-recipient><name><surname>McCormick</surname><given-names>Peter J</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Ministerio de Economia y Competitividad</institution></institution-wrap></funding-source><award-id>RTI2018-094374-B-I00</award-id><principal-award-recipient><name><surname>Ginés</surname><given-names>Silvia</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008666</institution-id><institution>Fundació la Marató de TV3</institution></institution-wrap></funding-source><award-id>20140610</award-id><principal-award-recipient><name><surname>Canela</surname><given-names>Enric I</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>Jerome LeJeune Foundation</institution></institution-wrap></funding-source><award-id>FJL-01/01/2013</award-id><principal-award-recipient><name><surname>McCormick</surname><given-names>Peter J</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution>Ministerio de Economia y Competitividad</institution></institution-wrap></funding-source><award-id>SAF2017-88076-R</award-id><principal-award-recipient><name><surname>Alberch</surname><given-names>Jordi</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution>Ministerio de Economia y Competitividad</institution></institution-wrap></funding-source><award-id>RTI2018-095311-B-I00</award-id><principal-award-recipient><name><surname>Guzmán</surname><given-names>Manuel</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All procedures involving animals were performed in compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals, and approved by the local animal care committee of the Universitat de Barcelona (99/01) and Generalitat de Catalunya (99/1094), in accordance with the European (2010/63/EU) and Spanish (RD53/2013) regulations for the care and use of laboratory animals. All protocols involving postmortem human sample were approved by the institutional ethic committees.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><supplementary-material><ext-link xlink:href="elife-51093-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>